UniSector: BioPharma A

LU0101441086UCITS FundEURAusschüttendFigures as of September 30, 2026
See this fund's PDF factsheetFree with an account · your firm's name in the header
Global Gesundheitswesen Equity
RiskMediumConcentrationBalancedRegionGlobal · Vereinigte Staaten tiltSectorGesundheitswesen

UniSector: BioPharma A is a global gesundheitswesen equity ucits fund from Union Investment with a total expense ratio of 1.80% and a risk indicator of 4 on the 1–7 scale. Its ten largest positions weigh 49.3% of the portfolio, which FundFacts classifies as balanced. Regional focus: Global with a Vereinigte Staaten tilt. Sector tilt: Gesundheitswesen.

Key facts

TER1.80%
Fund sizeEUR 669.61m
InceptionOctober 1, 1999
Asset classEquities
BenchmarkMSCI World Health Care Index

Risk indicator (SRRI)

1
2
3
4
5
6
7
Lower risk · lower rewardHigher risk · higher reward
Volatility 3y13.1%
Max drawdown-22.9%

Investment objective

Ziel des Aktienfonds (einem Teilfonds des Umbrella-Fonds UniSector) ist es, neben der Erwirtschaftung marktgerechter Erträge langfristig ein Kapitalwachstum zu erwirtschaften. Das Fondsvermögen wird weltweit in Unternehmen aus der Pharma-, Gesundheits- und der Biotechnologiebranche investiert. Die Anlagestrategie orientiert sich an einem Vergleichsmaßstab (100% MSCI World Health Care (total return, net dividends, auf Euro-Basis)), wobei versucht wird, dessen Wertentwicklung zu übertreffen.

Fund details

ISINLU0101441086
Fund houseUnion Investment
StructureUCITS Fund
Share class currencyEUR
Distribution policyAusschüttend
DomicileLuxembourg
Launch dateOctober 1, 1999
BenchmarkMSCI World Health Care Index
Asset classEquities
Fund sizeEUR 669.61m

Fees and costs

Total expense ratio (TER)1.80%
Ongoing charges1.80%
Transaction costs1.30%
Entry charge3.90%
Exit charge0.00%
Performance fee0.00%
Reduction in yield, 1 year6.90%
Reduction in yield, holding period3.80%
Recommended holding period7 years

Growth of 100 since inception

10015020020172019202120232025
Fund165MSCI World Health Care Index202
2015-12 → 2025-12 · rebased to 100
Computed from the NAV history the issuer publishes, monthly observations, rebased to 100 at the first point.

Calendar-year returns

−0.9%2016−1.1%2017+3.7%2018+23.5%2019+0.4%2020+29.2%2021−1.0%2022+0.3%2023+3.4%2024−1.5%2025
Fund MSCI World Health Care Index

Annualised returns

PeriodFund
1 Year+14.32%
3 Years p.a.+2.81%
5 Years p.a.+3.15%
10 Years p.a.+5.96%
Since Inception+5.60%

Largest sectors

  1. Gesundheitswesen97.5%
  2. Immobilien1.2%
  3. Nicht-Basiskonsumgüter0.5%
  4. Finanzwesen0.4%

Largest countries

  1. Vereinigte Staaten72.8%
  2. Schweiz9.3%
  3. Vereinigtes Königreich4.5%
  4. Deutschland3.6%
  5. Irland1.8%
  6. Israel1.7%
  7. Japan1.1%
  8. Dänemark0.9%
  9. Niederlande0.9%
  10. Belgien0.8%

Concentration

Top 10 weight 49.3% — balanced
  1. 01Eli Lilly and Co.9.25%
  2. 02Johnson & Johnson8.39%
  3. 03AbbVie Inc.6.05%
  4. 04Merck & Co. Inc.4.06%
  5. 05UnitedHealth Group Inc.3.93%
  6. 06AstraZeneca Plc.3.79%
  7. 07Thermo Fisher Scientific Inc.3.77%
  8. 08Roche Holding AG Partizipationsscheine3.65%
  9. 09Gilead Sciences Inc.3.40%
  10. 10Abbott Laboratories3.01%
Full holdings (—) in the API payload.

Frequently asked questions

What is the TER of UniSector: BioPharma A?

The total expense ratio (TER) of UniSector: BioPharma A (LU0101441086) is 1.80% per year.

How risky is UniSector: BioPharma A?

UniSector: BioPharma A has a risk indicator (SRRI) of 4 on a scale from 1 (lower risk) to 7 (higher risk), which FundFacts places in the medium risk band. Its 3-year volatility is 13.1%. Its maximum drawdown is -22.9%.

What are the top holdings of UniSector: BioPharma A?

The largest positions of UniSector: BioPharma A as of September 30, 2026 are Eli Lilly and Co. (9.25%), Johnson & Johnson (8.39%), AbbVie Inc. (6.05%), Merck & Co. Inc. (4.06%) and UnitedHealth Group Inc. (3.93%). Its ten largest holdings make up 49.3% of the portfolio.

What does UniSector: BioPharma A invest in?

UniSector: BioPharma A is a global gesundheitswesen equity ucits fund. Its largest exposures as of September 30, 2026 are by country, Vereinigte Staaten 72.8%, Schweiz 9.3% and Vereinigtes Königreich 4.5%; by sector, Gesundheitswesen 97.5%, Immobilien 1.2% and Nicht-Basiskonsumgüter 0.5%.

How has UniSector: BioPharma A performed?

UniSector: BioPharma A returned +14.32% over one year, +3.15% a year over five years and −1.5% in calendar year 2025 as of September 30, 2026, according to the NAV history Union Investment publishes. Past performance does not predict future returns.

Is UniSector: BioPharma A accumulating or distributing?

UniSector: BioPharma A is a distributing share class: it pays out the income from its holdings to investors.

Which index does UniSector: BioPharma A track?

UniSector: BioPharma A's benchmark is the MSCI World Health Care Index.

Where is UniSector: BioPharma A domiciled and what is its SFDR classification?

UniSector: BioPharma A is domiciled in Luxembourg (ISIN LU0101441086).

Where does this data about UniSector: BioPharma A come from?

FundFacts reads it from the documents Union Investment publishes for this share class — product page, factsheet, key information document and, where available, holdings and NAV files — and refreshes it every 24 hours. The same factsheet is available as JSON from the FundFacts API.

Download this fund as a PDF factsheet

A one-page PDF or web factsheet with the figures of this page, branded for your clients: your name in the header, your accent colour, a permanent link to share. Free with an account, ready in a minute.

Get this factsheet as JSON

Everything on this page, with the largest holdings, every breakdown, the monthly series and the risk statistics, is one REST call. Any fund or ETF by ISIN, refreshed every 24 hours from the issuer's own documents.
curl https://fundfactsapi.com/api/v1/demo/funds/LU0101441086
​
# any ISIN, with a free API key
curl https://fundfactsapi.com/api/v1/funds/LU0101441086 -H "Authorization: Bearer ffk_..."

Ask Claude about this fund

Open a Claude conversation about UniSector: BioPharma A with this page as the source. Add the FundFacts MCP connector and Claude gets the same factsheet for every ISIN you ask about: fees, holdings, exposure, returns, overlap and portfolio look-through, with the as-of date of each figure.
Figures are read from the documents Union Investment publishes for this share class (product page, factsheet, key information document and, where available, holdings and NAV files), as of September 30, 2026. The category, risk band, concentration and tilt labels are the FundFacts profile (fundfacts-profile/3), derived from those figures with fixed, published rules. FundFacts API is independent and not affiliated with, sponsored or endorsed by Union Investment; fund names are used to identify the product only. Nothing on this page is investment advice.